Ironwood Pharmaceuticals Stock Price History
IRWD Stock | USD 3.66 0.12 3.17% |
Below is the normalized historical share price chart for Ironwood Pharmaceuticals extending back to February 03, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ironwood Pharmaceuticals stands at 3.66, as last reported on the 18th of January 2025, with the highest price reaching 3.81 and the lowest price hitting 3.58 during the day.
If you're considering investing in Ironwood Stock, it is important to understand the factors that can impact its price. Ironwood Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0148, which attests that the entity had a -0.0148% return per unit of risk over the last 3 months. Ironwood Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Ironwood Pharmaceuticals' Standard Deviation of 5.25, risk adjusted performance of (0.01), and Market Risk Adjusted Performance of (0.08) to validate the risk estimate we provide.
Sale Purchase Of Stock is expected to grow at the current pace this year, whereas Total Stockholder Equity is projected to grow to (378.3 M). . At present, Ironwood Pharmaceuticals' Price To Operating Cash Flows Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Cash Flow Ratio is expected to grow to 9.16, whereas Price Earnings Ratio is forecasted to decline to (2.14). Ironwood Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of February 2010 | 200 Day MA 5.4105 | 50 Day MA 4.0092 | Beta 0.475 |
Ironwood |
Sharpe Ratio = -0.0148
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | IRWD |
Estimated Market Risk
5.36 actual daily | 47 53% of assets are more volatile |
Expected Return
-0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ironwood Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ironwood Pharmaceuticals by adding Ironwood Pharmaceuticals to a well-diversified portfolio.
Price Book 2.5899 | Enterprise Value Ebitda 10.6582 | Price Sales 1.5985 | Shares Float 132.2 M | Wall Street Target Price 12.5 |
Ironwood Pharmaceuticals Stock Price History Chart
There are several ways to analyze Ironwood Stock price data. The simplest method is using a basic Ironwood candlestick price chart, which shows Ironwood Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 6, 2024 | 5.04 |
Lowest Price | November 21, 2024 | 3.34 |
Ironwood Pharmaceuticals January 18, 2025 Stock Price Synopsis
Various analyses of Ironwood Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Ironwood Stock. It can be used to describe the percentage change in the price of Ironwood Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Ironwood Stock.Ironwood Pharmaceuticals Price Daily Balance Of Power | (0.52) | |
Ironwood Pharmaceuticals Price Rate Of Daily Change | 0.97 | |
Ironwood Pharmaceuticals Price Action Indicator | (0.09) |
Ironwood Pharmaceuticals January 18, 2025 Stock Price Analysis
Ironwood Stock Price History Data
The price series of Ironwood Pharmaceuticals for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 has a statistical range of 1.7 with a coefficient of variation of 10.93. Under current investment horizon, the daily prices are spread out with arithmetic mean of 4.05. The median price for the last 90 days is 4.08. The company completed 1194:1000 stock split on 2nd of April 2019. Ironwood Pharmaceuticals completed dividends distribution on April 2, 2019.Open | High | Low | Close | Volume | ||
01/18/2025 | 3.81 | 3.81 | 3.58 | 3.66 | ||
01/17/2025 | 3.81 | 3.81 | 3.58 | 3.66 | 1,858,036 | |
01/16/2025 | 3.72 | 3.83 | 3.56 | 3.78 | 1,447,852 | |
01/15/2025 | 3.74 | 3.88 | 3.65 | 3.74 | 1,544,151 | |
01/14/2025 | 3.77 | 3.83 | 3.64 | 3.65 | 980,919 | |
01/13/2025 | 3.87 | 3.90 | 3.53 | 3.77 | 2,280,954 | |
01/10/2025 | 4.64 | 4.64 | 3.95 | 3.96 | 1,692,295 | |
01/08/2025 | 4.53 | 4.77 | 4.33 | 4.58 | 2,775,763 | |
01/07/2025 | 4.52 | 4.78 | 4.43 | 4.53 | 2,198,487 | |
01/06/2025 | 4.56 | 4.62 | 4.43 | 4.50 | 2,270,755 | |
01/03/2025 | 4.33 | 4.68 | 4.24 | 4.51 | 3,797,687 | |
01/02/2025 | 4.50 | 4.54 | 4.19 | 4.33 | 1,737,358 | |
12/31/2024 | 4.39 | 4.51 | 4.36 | 4.43 | 2,150,245 | |
12/30/2024 | 4.37 | 4.50 | 4.34 | 4.38 | 910,377 | |
12/27/2024 | 4.54 | 4.62 | 4.31 | 4.45 | 1,767,082 | |
12/26/2024 | 4.58 | 4.69 | 4.30 | 4.59 | 861,978 | |
12/24/2024 | 4.63 | 4.70 | 4.56 | 4.61 | 824,688 | |
12/23/2024 | 4.47 | 4.63 | 4.33 | 4.59 | 2,143,553 | |
12/20/2024 | 3.89 | 5.13 | 3.78 | 4.45 | 11,008,902 | |
12/19/2024 | 3.46 | 3.93 | 3.37 | 3.88 | 3,930,836 | |
12/18/2024 | 3.56 | 3.69 | 3.41 | 3.46 | 2,534,998 | |
12/17/2024 | 3.38 | 3.65 | 3.38 | 3.53 | 2,369,738 | |
12/16/2024 | 3.50 | 3.61 | 3.38 | 3.45 | 3,219,859 | |
12/13/2024 | 3.57 | 3.62 | 3.43 | 3.53 | 1,952,513 | |
12/12/2024 | 3.63 | 3.75 | 3.48 | 3.56 | 2,859,420 | |
12/11/2024 | 3.72 | 3.75 | 3.39 | 3.69 | 1,928,791 | |
12/10/2024 | 4.04 | 4.04 | 3.64 | 3.72 | 2,151,216 | |
12/09/2024 | 3.44 | 4.05 | 3.41 | 3.98 | 2,597,509 | |
12/06/2024 | 3.25 | 3.43 | 3.06 | 3.43 | 2,952,905 | |
12/05/2024 | 3.55 | 3.60 | 3.31 | 3.34 | 1,309,130 | |
12/04/2024 | 3.53 | 3.68 | 3.49 | 3.55 | 1,188,229 | |
12/03/2024 | 3.59 | 3.64 | 3.46 | 3.54 | 1,131,856 | |
12/02/2024 | 3.50 | 3.65 | 3.46 | 3.62 | 1,399,831 | |
11/29/2024 | 3.72 | 3.73 | 3.44 | 3.52 | 858,094 | |
11/27/2024 | 3.52 | 3.71 | 3.44 | 3.67 | 1,126,908 | |
11/26/2024 | 3.35 | 3.63 | 3.28 | 3.52 | 2,561,448 | |
11/25/2024 | 3.49 | 3.59 | 3.32 | 3.35 | 2,683,630 | |
11/22/2024 | 3.33 | 3.50 | 3.26 | 3.44 | 1,773,910 | |
11/21/2024 | 3.53 | 3.74 | 3.31 | 3.34 | 2,566,590 | |
11/20/2024 | 3.78 | 3.80 | 3.51 | 3.52 | 1,613,612 | |
11/19/2024 | 3.96 | 4.00 | 3.80 | 3.81 | 1,520,135 | |
11/18/2024 | 4.20 | 4.20 | 3.99 | 4.02 | 1,263,848 | |
11/15/2024 | 4.14 | 4.26 | 3.96 | 4.21 | 1,543,522 | |
11/14/2024 | 4.30 | 4.41 | 4.10 | 4.11 | 1,700,575 | |
11/13/2024 | 4.35 | 4.47 | 4.27 | 4.31 | 1,158,923 | |
11/12/2024 | 4.80 | 4.86 | 4.28 | 4.39 | 1,582,363 | |
11/11/2024 | 5.06 | 5.07 | 4.78 | 4.78 | 1,283,199 | |
11/08/2024 | 4.72 | 4.97 | 4.67 | 4.96 | 1,569,955 | |
11/07/2024 | 4.28 | 4.86 | 4.26 | 4.66 | 2,112,383 | |
11/06/2024 | 4.91 | 5.05 | 4.74 | 5.04 | 3,115,721 | |
11/05/2024 | 4.12 | 4.51 | 4.06 | 4.49 | 1,478,164 | |
11/04/2024 | 4.16 | 4.31 | 4.13 | 4.19 | 1,146,673 | |
11/01/2024 | 4.04 | 4.20 | 3.99 | 4.19 | 1,066,402 | |
10/31/2024 | 4.16 | 4.16 | 3.93 | 3.95 | 2,344,936 | |
10/30/2024 | 4.21 | 4.35 | 4.14 | 4.15 | 809,016 | |
10/29/2024 | 4.10 | 4.33 | 4.01 | 4.25 | 1,457,898 | |
10/28/2024 | 4.08 | 4.36 | 4.07 | 4.15 | 1,054,805 | |
10/25/2024 | 4.00 | 4.11 | 3.93 | 3.96 | 736,335 | |
10/24/2024 | 3.96 | 4.06 | 3.90 | 3.98 | 923,072 | |
10/23/2024 | 4.09 | 4.13 | 3.91 | 3.98 | 1,088,485 | |
10/22/2024 | 4.12 | 4.21 | 4.06 | 4.08 | 822,061 |
About Ironwood Pharmaceuticals Stock history
Ironwood Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ironwood is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ironwood Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ironwood Pharmaceuticals stock prices may prove useful in developing a viable investing in Ironwood Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 178.8 M | 137.1 M | |
Net Income Applicable To Common Shares | 201.3 M | 211.4 M |
Ironwood Pharmaceuticals Stock Technical Analysis
Ironwood Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
All Next | Launch Module |
Ironwood Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ironwood Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Ironwood Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ironwood to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.01) | |||
Jensen Alpha | (0.14) | |||
Total Risk Alpha | (0.24) | |||
Treynor Ratio | (0.09) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Ironwood Stock analysis
When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |